Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy

Paola Magro; Beatrice Formenti; Valentina Marchese; Maurizio Gulletta; Lina Rachele Tomasoni; Silvio Caligaris; Francesco Castelli; Alberto Matteelli

doi:10.1183/13993003.02665-2020

Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy

Eur Respir J. 2020 Oct 1;56(4):2002665. doi: 10.1183/13993003.02665-2020. Print 2020 Oct.

Authors

Paola Magro^{1

2

3}, Beatrice Formenti^{4

3}, Valentina Marchese^{2

5}, Maurizio Gulletta⁶, Lina Rachele Tomasoni⁶, Silvio Caligaris⁶, Francesco Castelli^{1

2}, Alberto Matteelli^{1

2}

Affiliations

¹ Dept of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili, Brescia, Italy.
² WHO Collaborating Centre for TB/HIV and TB elimination, Brescia, Italy.
³ These authors contributed equally.
⁴ Dept of Infectious Diseases, ASST Spedali Civili of Brescia, Brescia, Italy [email protected].
⁵ Specialist Consultation Service, ASST Spedali Civili of Brescia, Brescia, Italy.
⁶ Unit of Tropical Diseases, ASST Spedali Civili, Brescia, Brescia, Italy.

Abstract

It is important to recognise the impact of COVID-19 on TB care to mitigate its consequences. TB services have an urgent need to identify novel strategies to ensure the continuum of TB care at the time of the coronavirus pandemic. https://bit.ly/2OIKnwL

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections / epidemiology*
Humans
Italy
Pandemics*
Pneumonia, Viral / epidemiology*
SARS-CoV-2
Severe Acute Respiratory Syndrome*
Treatment Outcome
Tuberculosis*